Consequently, PTL was discovered to be capable of inducing robust apoptosis in primary acute myelogenous leukemia (AML) cells (Guzman et al., 2007 ▸), proving to be equally effective among all subpopulations within primary AML specimens, including leukemia stem cells (LSCs). Here, PNLIP is linked to acute myeloid leukemia.